MedTrace Logo

The Effect of Hypnobreastfeeding Education Given to Primiparas

NCT06493630 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2025-12-19

No results posted yet for this study

Summary

Hypnobreastfeeding is one of the education-based interventions used in this field. This study aims to evaluate the effect of hypnobreastfeeding education given to primiparous pregnant women on breastfeeding myths, breastfeeding expectations and breastfeeding self-efficacy. According to the results of the power analysis, at least 104 pregnant women, 52 experimental and 52 control, should be included in the study. Data were collected with the "Pregnant Introduction Form", "Breastfeeding Myths Scale", "Breastfeeding Expectations Scale-A" and "Prenatal Breastfeeding Self-Efficacy Scale". In the research, hypnobreastfeeding training was applied by the researcher to the primiparous pregnant women in the experimental group. The study was completed with 110 primiparous pregnant women, 54 in the experimental group and 56 in the control group.

Conditions

  • Breastfeeding
  • Self Efficacy
  • Expectations

Interventions

BEHAVIORAL

Hypnobreastfeeding Education

Hypnobreastfeeding Education: Monitoring breastfeeding myths, breastfeeding expectations and breastfeeding self-efficacy with hypnobreastfeeding education

Sponsors & Collaborators

  • Amasya University

    lead OTHER

Principal Investigators

  • Emine İbici Akça · Amasya University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-10-01
Primary Completion
2025-02-01
Completion
2025-05-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06493630 on ClinicalTrials.gov